MicroRNA-31 negatively regulates peripherally derived regulatory T-cell generation by repressing retinoic acid-inducible protein 3
It is currently one of the few medications for treating obesity that the FDA has formally approved
When GLP1s suppress appetite, the risk of unintended muscle loss is real unless resistance training and adequate protein intake are prioritized
519 Therapeutic targeting of proteostasis in autoimmune diseases Autoimmune diseases are characterized by chronic immune activation, inflammatory tissue injury, and failure of immune tolerance
Contributor Disclaimer: As a service to our readers, Harvard Health Publishing provides access to our library of archived content
Whether you're healing from an injury, managing inflammation, or enhancing recovery from training, it deserves a place in your recovery toolkit